# A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers

> **NCT02220153** · PHASE1 · COMPLETED · sponsor: **UCB Celltech** · enrollment: 41 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** UCB7665 Intravenous 1
- **BIOLOGICAL:** UCB7665 Intravenous 2
- **BIOLOGICAL:** UCB7665 Intravenous 3
- **BIOLOGICAL:** UCB7665 Intravenous 4
- **BIOLOGICAL:** UCB7665 Intravenous 5
- **BIOLOGICAL:** UCB7665 Subcutaneous 1
- **BIOLOGICAL:** UCB7665 Subcutaneous 2
- **BIOLOGICAL:** Intravenous Placebo
- **BIOLOGICAL:** Subcutaneous Placebo

## Key facts

- **NCT ID:** NCT02220153
- **Lead sponsor:** UCB Celltech
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2015-10-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02220153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02220153, "A First-In-Human Study With a Single Dose UCB7665 in Healthy Volunteers". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT02220153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*